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1. INTRODUCTION   
 
In this chapter we describe the concept of MobiHealth and the approach developed 
during the MobiHealth project (MobiHealth, 2002). The concept was to bring together 
the technologies of Body Area Networks (BANs), wireless broadband communications 
and wearable medical devices to provide mobile healthcare services for patients and 
health professionals. These technologies enable remote patient care services such as 
management of chronic conditions and detection of health emergencies. Because the 
patient is free to move anywhere whilst wearing the MobiHealth BAN, patient mobility is 
maximised.  The vision is that patients can enjoy enhanced freedom and quality of life 
through avoidance or reduction of hospital stays. For the health services it means that 
pressure on overstretched hospital services can be alleviated. 
During the project a generic BAN for healthcare and a generic m-health service 
platform was developed, trialled and evaluated. The MobiHealth BAN incorporates body-
worn devices and handles communication amongst those devices. The MobiHealth 
Service Platform manages (a population of) deployed BANs and handles external 
communication between the BANs and a remote healthcare location.  
During the course of the project the main BAN devices used were medical sensors. 
Biosignals measured by sensors connected to the BAN were transmitted to a remote 
healthcare location over 2.5/3G public wireless networks (GPRS and UMTS). The 
MobiHealth BAN and service platform were trialled in four European countries with a 
variety of patient groups. The trials focussed on home care, trauma care and outdoor 
settings. The remote healthcare locations involved were hospitals in Spain, The 
Netherlands and Sweden and a medical call center in Germany. The remote monitoring 
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services allow patients to follow their normal daily life activities rather than being 
confined to hospital or to their home during monitoring.  
The overall goal of MobiHealth was to evaluate the ability of 2.5 and 3G 
communication technologies to support innovative mobile health services. The main 
output of the project therefore is an assessment of the suitability of GPRS and UMTS to 
support such services. In addition the project delivers an architecture for, and a prototype 
of, a health BAN and a generic m-health service platform for provision of ubiquitous 
healthcare services based on Body Area Networks.  
The MobiHealth concept arose out of work at the University of Twente since 1999 
(Jones et al., 1999; Jones 2001) and was further developed within the work of the 
Wireless World Research Forum (Jones et al., 2001b; Jones et al., 2001c; WWRF, 2001). 
The MobiHealth consortium involving 14 European partners was brought together during 
2001. The project began on May 1st 2002 and is funded by the European Commission 
under IST FP5 and has been reported in (Jones et al, 2001a; Konstantas et al., 2002a,b; 
Widya et al., 2003a, Dokovsky et al., 2003). The project coordinator is Ericsson GmbH 
with the University of Twente taking the scientific lead.  
The MobiHealth System can support not only sensors, but potentially any body worn 
(medical) device provided it has a communication interface. (An example of another kind 
of device already used with the BAN is a Bluetooth enabled digital camera.) Hence the 
system has potentially very many applications in healthcare. Some of these are explored 
in other chapters in this book. The chapter entitled Telematic Reequirements for 
Emergency and Disaster Response (Widya et al, 2003b) models the extension of the 
MobiHealth Trauma application to large scale disaster and emergency scenarios.  
Another chapter entitled Remote Monitoring for Healthcare and for Safety in Extreme 
Environments (Jones et al, 2003) examines the potential of the MobiHealth approach for 
provision of remote monitoring services to support work and recreation in extreme 
environments. That chapter focuses on polar and underwater environments as examples.  
This remainder of this chapter presents the MobiHealth technology (Section 2), the 
trials and the evaluation (Section 3), and identifies some of the research issues raised by 
the project (Section 4).  
 
 
2. THE MOBIHEALTH TECHNOLOGY  
  
A mobile health BAN and a generic service platform for BAN services for patients 
and health professionals were developed as part of the work of the MobiHealth project. 
Remote (patient) monitoring services are just one of the kinds of services that can be 
provided by such a platform. Here we focus on monitoring as an example of BAN 
services in order to present the MobiHealth technology.  
A wide range of patient monitoring equipment is used in healthcare. Traditionally 
monitoring equipment was operated by health professionals in hospitals or at other 
healthcare locations. Some of the equipment is quite bulky and heavy, but for some kinds 
of monitoring the use of small ambulatory monitors together with telemetry has improved 
mobility for patients within the hospital.  
Nowadays there is an extensive range of miniature wearable monitors available. Some 
are on sale to the public as consumer electronics products. A wrist worn blood pressure 
and heart rate monitor can be purchased for as little as 30 Euro. Such products can be 
used for example by cardiac patients to monitor their own health state and response to 
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medication. Another wrist-worn device allows diabetes patients to monitor their blood 
glucose non-invasively. Some products provide local processing only (such as readouts, 
logging of readings, reminders, warnings and alarms). Some also allow upload of data to 
a PC whilst others combine monitoring and (tele)communication functions. One example 
is a cardiac monitoring product embedded in a mobile phone, which transmits cardiac 
signals to a doctor or a to a distant healthcare location over public cellular networks. 
Some products incorporate positioning to provide positioning information in case of 
emergency so that the emergency services can locate the casualty easily. There are also 
many examples of commercially available wearable monitoring systems targeted at non-
patients. Examples are heart monitors for use by athletes during training and motion 
sensors and gas sensors used to protect workers in the chemical industry. 
With so many devices available, why do we need to introduce the concept of a Body 
Area Network? In the next section we explain the concept of Body Area Networks 
(BANs), and why we apply a BAN approach in MobiHealth.  
 
2.1. Body Area Networks 
 
The concept of the Body Area Network originally came from IBM (Zimmerman, 
1999) and was developed further by many other researchers, for example at Philips (van 
Dam, 2001), at the University of Twente (Jones et al., 2001a; Jones et al., 2001b), and at 
Fraunhofer (Schmidt, 2001). In the Wireless World Research Forum’s Book of Visions, 
we define a BAN as “a collection of (inter) communicating devices which are worn on 
the body, providing an integrated set of personalised services to the user” (WWRF, 
2001). For the purposes of the MobiHealth project a BAN can be thought of simply as a 
computer network which is worn on the body and which moves around with the person 
(that is, it is the unit of roaming). 
A BAN incorporates a set of devices which perform some specific functions and 
which also perform communication, perhaps via a central controlling device. Devices 
may be simple devices such as sensors or actuators, or more complex multimedia devices 
such as cameras, microphones, audio headsets or media players such as MP3 players. The 
central controlling device (if there is one) may perform computation, coordination and 
communication functions. Communication amongst the elements of a BAN is called 
intra-BAN communication. If the BAN communicates externally, i.e. with other networks 
(which may themselves be BANs), this communication is seen (from the point of view of 
the BAN itself) as extra-BAN communication. 
 
2.1.1. Intra-BAN Communication  
 
IntraBAN communication is carried over a wired or a wireless medium. Wired 
options include copper wires, of course, also optical fibre and many ‘wearable 
computing’ solutions where circuitry is embedded in or woven into or printed onto fabric 
or incorporated into ‘body furniture’ such as spectacles or jewelry.  
Wireless options include infrared light, microwave, radio and even skin conductivity. 
Two important standards for short range wireless communication are Bluetooth and 
Zigbee. Bluetooth (Bluetooth, 2003) is an example of a wireless communication standard 
(IEEE 802.15) based on radio waves. It supports speeds of up to 721 Kbps and offers a 
user-friendly way of  ‘ad hoc’ networking providing automatic admission and removal of 
devices in a network. The range is up to approximately 100m. Although a very attractive 
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technology for BANs, the relatively high power consumption for wireless transmissions 
make long term unattended use of a Bluetooth BAN problematic. ZigBee (ZigBee 
Alliance) (also known as RF-lite) is a low cost, low power, two-way wireless 
communications standard (IEEE 802.15.4) and is particularly promising for BANs. 
ZigBee supports a relatively low data rate (< 250 Kbps), but combines this with long 
battery lifetime. The range is approximately 50m. 
 
2.1.2. Extra-BAN Communications  
 
To support convenience and mobility for the BAN user, extra-BAN communication 
is in general based on wireless technologies. A range of technologies is available 
including Bluetooth, WLAN, GSM, GPRS and UMTS. The selection of transmission 
technology will depend largely on range and (transmission) speed requirements. There 
are other important criteria (e.g. reliability, security) for communication links, but these 
can be fulfilled by application level protocols. Bluetooth and WLAN (Wireless Local 
Area Network) are short and medium range communication technologies (Bluetooth 10m 
and WLAN 100m) and depend on a local infrastructure (within a building for example). 
GSM, GPRS and UMTS are wide area technologies, offering the possibility for the 
wearer of the BAN to be truly mobile (i.e. have the freedom to go anywhere without 
losing connectivity). 
GSM (also called 2nd Generation, or 2G, technology) is as a voice network and has 
national coverage in many countries. Pan-European coverage is made possible by means 
of international agreements between network operators. GSM can also be used as a data 
network and offers a minimum guaranteed speed of 9.6/14.4kbps. GPRS (an instance of 
the so-called 2.5G technologies) is a voice and data network running over the GSM 
infrastructure. GSM timeslots not assigned to voice connections can be used for data 
transmission, however voice has priority, creating potential quality of service problems 
for data transmission. GPRS offers transmission speeds of up to ~50kbps. New 
technological developments are expected to result in increased speed for GPRS 
communications. UMTS (a 3G technology) promises wideband communication speeds of 
up to 2Mbps. At time of writing UMTS rollout is underway but with coverage limited to 
heavily populated areas (e.g. urban areas). Initial UMTS networks are expected to 
support a transmission speed of 64kbps, with an option for 144kbps.   
 
2.1.3. Body Area Networks for Healthcare 
 
The Body Area Network is a generic concept which can have many applications in 
various domains. When the devices of a BAN measure physiological signals or perform 
other actions for health-related purposes we call this kind of specialization of Body Area 
Networks a health BAN. As a further specialisation, a BAN whose devices are biosignal 
sensors enables patient monitoring. Clearly there can be different kinds of sensors for 
monitoring different biosignals. Thus we can envisage any number of specific health 
BANs for specific classes of patients/clinical conditions. Some example applications are: 
cardiac care, diabetes management, sleep analysis, asthma, epilepsy, EEG/EMG 
monitoring, SIDS, care of the elderly, assistive technologies for the disabled, movement 
analysis, feedback on medication (e.g. for Parkinsons disease), monitoring of drug 
delivery systems (e.g. morphine or insulin pump) and home cancer care.  
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If we combine health BANs with extra-BAN communications this enables remote 
monitoring of patients. This can be achieved by means of fixed networks, such as a fixed 
(wired) telephone line or an Internet connection, allowing the patient to be monitored at 
home instead of in hospital for example. However the fixed line limits the mobility of the 
patient to a fixed position during monitoring, or at least during regular uploading of 
locally stored monitor data. Store and upload is only feasible when there are no real-time 
requirements (such as emergency detection and alarms) and is dependent on storage 
capacity of the wearable device. Some applications generate only small amounts of 
biosignal data, but others are very data intensive. For example epilepsy monitoring with 
32 channels generates 400-500 MB per day and 128 channel monitoring brings (daily) 
storage requirements into the Gigabyte range.  
Combining BANs with extra-BAN wireless communications enables remote 
(ambulatory) monitoring and full mobility for the patient with support of real-time 
applications. This means that the patient can pursue normal life activities, leave the house 
and even travel anywhere in the world, insofar as their health condition permits. In other 
words wireless communication services open up the possibility of location freedom 
(global roaming) for patients who are undergoing monitoring. 
In the following section we describe the approach of the MobiHealth Project to the 
use of health BANs for remote monitoring of patients.  
 
2.2. The MobiHealth Body Area Network  
 
One problem with some of the currently available monitoring devices is that they are 
closed proprietary (non-interoperable) systems; some even operate in a standalone 
fashion with no option to upload measurements. Whilst these devices have utility and 
have clearly found a market, the usefulness of such devices can be enhanced in a number 
of ways. The vision of the MobiHealth project is to develop an open extensible BAN 
platform which allows integration of different health functions by means of a (wireless) 
plug-and-play approach.  
The use of the MobiHealth BAN together with 2.5/3G communications means that 
biosignals measured by the BAN can be transmitted to a remote (healthcare) location. 
This enables remote management of chronic conditions and detection of health 
emergencies whilst giving the patient the freedom to move anywhere outside the hospital. 
At time of writing the MobiHealth system is being tested by patients and health 
professionals in home care, trauma care and outdoor settings. The MobiHealth BAN also 
features in a sister project called xMotion where it is integrated into a UMTS based tele-
ambulance demonstrator (xMotion, 2002).).  
 
2.2.1. Architecture of the MobiHealth system 
 
The MobiHealth BAN consists of a central unit known as the MBU (Mobile Base Unit) 
and a set of body-worn devices, which may include sensors, actuators, and various 
multimedia devices. In principle the BAN may incorporate any wearable or implantable 
devices. Figure 1 shows the generic architecture of the BAN.  
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Figure 1. Generic architecture of the BAN. 
 
The MBU can be thought of as a gateway which handles extraBAN communication. It 
also handles coordination, local computation and communication amongst BAN devices. 
It can also host local applications such as a local viewer application, or (in future) more 
complicated functionality such as disease management applications.  
In MobiHealth the MBU was implemented on an iPAQ H3870. This device has built-
in Bluetooth capabilities and can be extended with a GPRS jacket. Figure 2 shows the 
MBU running a viewer application to display biosignals measured by a sensor (in this 
case pulse plethysmogram measured by a pulse oximeter).  
 
 
Figure 2. MBU platform (iPAQ H3870), displaying output from pulse oximeter 
 
Sensor data is processed by a sensor front-end before being transmitted to the MBU. A 
range of front-ends can be associated with an MBU, enabling customization of the BAN. 
Although the MBU currently used in the MobiHealth trials is based on the HP iPAQ 
platform, future plans include porting to a cell phone platform such as the Sony Ericsson 
P800. The hardware components of a BAN are shown in Figure 3 which shows (left to 
right) an MBU, a sensor front-end (known as a “Mobi”) and a sensor set consisting of 
ECG electrodes and a motion sensor. 
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Figure 3.  MBU, sensor front-end end and a sensor set 
 
The BAN is only part of the overall MobiHealth system. Figure 4 shows the hardware 
and software architecture of the MobiHealth system. The lower part of the figure shows 
the hardware configuration and the upper part shows the software components developed 
during the course of the project to implement the MobiHealth BAN and its support 
services. The MobiHealth system includes not only the BANs deployed in the community 
but also the Back End System (BESys). The BESys is the m-health service runtime 
environment, which hides the mobile nature of the service provider components (MBUs) 
and exports the service to the local environment of the healthcare centre. It is composed  
 
Figure 4. Hardware and software architecture 
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of several software components which may reside on one or more hardware nodes. Data 
is exchanged between the BAN and a remote (healthcare) location, which has its own  
 (perhaps legacy) systems in operation. If the remote healthcare location is a hospital then 
this would be the HIS (Hospital Information System).  
The MobiHealth Back End System mediates between the HIS and the BAN. The 
Back End System may be located at the hospital or at another location entirely. The BAN 
is shown here with a set of sensors (S), a set of actuators (A) and a set of other devices, 
all connected (wired) to the sensor front end (FE). The FE communicates with the MBU 
wirelessly (over Bluetooth).  The MBU software stack contains the BANware 
implemented on top of a Java virtual machine (J2ME, CDC and Personal profiles) (Sun 
Microsystems, 2003a) running under Linux. The Back End System runs on a server 
(possibly at the healthcare location, possibly at another site); it incorporates a Look Up 
Service (LUS) and hosts a surrogate, which represents and manages the BANs in the 
field. The end-user application may consist simply of a viewer application or (in future) 
some much more complex suite of applications interfacing to the clinical systems of the 
healthcare provider. The software components of the MobiHealth system were developed 
at the University of Twente and are available as Open Source software. 
 
2.2.2. BAN Devices  
 
The generic BAN is customized with different device sets for different applications. 
Some of the BAN devices used during the MobiHealth project are electrodes for 
measuring ECG, pulse oximeters for measuring oxygen saturation, sensors for measuring 
NIBP (non invasive blood pressure) and motion sensors.  
A sensor is responsible for the data acquisition process. A sensor system ensures that a 
physical phenomenon, such as patient movement, muscle activity or blood flow, is first 
converted to an electrical signal. This signal is then amplified, conditioned, digitized and 
communicated within the BAN. 
Sensors can be either self-supporting or front-end supported. Self-supporting sensors 
have their own power supply and facilities for amplification, conditioning, digitization 
and communication. In case of front-end supported sensors, multiple sensors share a 
power supply and data acquisition facilities. Consequently, front-end supported sensors 
typically operate on the same front-end clock and jointly provide multiplexed sensor 
samples as a single data block. This avoids the need for synchronization between sensors. 
Self-supporting sensors are independent building blocks of a BAN and ensure a highly 
configurable BAN. However, each sensor runs at its own internal clock and may have a 
different sample frequency. Consequently, synchronization between sensors may be 
needed. 
The sensors used in the MobiHealth trials are: electrodes for measuring ExG (where 
ExG can stand for ECG, EMG or EEG), activity sensors, respiration sensors and pulse 
oximeter. Other BAN connected devices apart from sensors are: marker/alarm button and 
digital camera. Readings from external devices (such as NIBP or forced spirometry) can 
be entered manually on the MBU for transmission.  
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2.2.3. Intra-BAN Communications 
 
The MobiHealth architecture allows for wired or wireless communications within the 
BAN, or a combination of the two. The current MobiHealth trials use wired 
communication from sensors to sensor front end and Bluetooth from the front end to the 
MBU. However the BAN has actually been implemented using both wired (front-end 
supported) sensors from TMSI and wireless (self-supporting) sensors from EISlab 
(Östmark et al, 2003). Both approaches use Bluetooth for intra-BAN communication. The 
front-end also allows ZigBee as an alternative intra-BAN communication technology.   
 
2.2.4. Extra-BAN Communications  
 
For communication between the BANs and the Back End System (extra-BAN 
communication), 2.5/3G public networks are used. The MBU communicates via 
Bluetooth to a GPRS or UMTS handset (cell phone); from there the signals are 
transmitted to the remote location. In order to abstract from wireless transmission 
technology, BAN to Internet communication, and vice versa, is based on the IP protocol. 
National GPRS coverage is available in all the countries where the trials are conducted 
(Germany, The Netherlands, Spain and Sweden). The first localised UMTS (test) 
infrastructures became available in Germany and the Netherlands part way through the 
project (during 2003). At time of writing the Dutch trials were using both GPRS and 
UMTS for extraBAN communication. In the other trial countries GPRS was being used, 
with early prospects for UMTS tests. Availability of commercial UMTS services will 
broaden the range of applications which can be supported by the BAN.  
 
2.3. The MobiHealth m-health Service Platform  
 
The m-health service platform supports the BAN based applications and isolates them 
from the details of the underlying communications services. It is this service platform 
which enables genericity and hardware independence. Hardware independence has 
already been demonstrated by use of sensors from different manufacturers and by the 
initial experiments with replacing the PDA implementation of the MBU by a cell phone 
implementation.  
 
2.3.1. Service Platform Architecture  
 
Figure 5 shows the functional architecture of the service platform. The dotted square 
boxes indicate the physical location where components of the service platform execute. 
The rounded boxes represent the functional layers of the architecture. The m-health 
service platform consists of sensor and actuator services, intra-BAN and extra-BAN 
communication providers and an m-health service layer. The intra-BAN and extra-BAN 
communication providers represent the communication services offered by intra-BAN 
communication networks (e.g. Bluetooth), and extra-BAN communication networks (e.g. 
UMTS), respectively. The m-health service layer integrates and adds value to the intra-
BAN and extra-BAN communication providers. The m-health service layer masks 
applications from specific characteristics of the underlying communication providers, 
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such as the inverted consumer-producer roles. 
 
 
Sensor /  
Actuator  
Services 
Intra BAN 
communication provider 
Extra BAN 
communication provider 
 
M-health service layer 
 
Applications 
Sensors Mobile Base Unit (gateway + host) Computing infrastructure (Healthcare provider) 
 
Applications 
 
Figure 5. Service platform functional architecture 
 
Applications which run on top of the service platform can either execute on the MBU 
(for local use by the patient or by a visiting nurse for example) or on the servers or 
workstations of the healthcare provider, for example at a health call centre or hospital. 
The services offered by the M-health service platform are: 
• BAN registration: the service platform maintains a list of active BANs and 
allows applications to retrieve the specific configuration of a BAN.  
• BAN discovery: applications can subscribe to the platform in order to receive a 
notification when a BAN becomes active (e.g. when a patient switches on a 
BAN). 
• BAN authorization and authentication: the service platform authenticates BANs 
and only allows authorized BANs to transfer data.  
• BAN data encryption: the platform encrypts data to be transmitted over 
unsecured networks 
• BAN configuration: the service platform allows online configuration and 
management of the BANs, such as activation and deactivation of specific 
sensors, or modification of sensor sampling frequency. 
• Data acquisition control: the service platform enables applications to start, stop 
or temporarily suspend the data acquisition process of a BAN. 
• Query and modify actuator status: applications can manipulate actuators from a 
distance. 
• BAN data storage: the service platform also offers intermediate storage services 
for the applications. The application can specify the minimum required lifetime 
of the stored data. 
• BAN data monitoring: the service platform can apply filtering algorithms to 
BAN data to determine if a significant event has taken place (e.g. a patient has 
fallen) and report this event to the application layer.  
Figure 6 shows a refined view of the m-health service layer. In this figure the m-health 
service platform user (e.g. a doctor at a hospital) is located remotely from a healthcare 
provider (in this case a health call center). The arrows indicate the flow of BAN data. The 
BANip entity is a protocol entity of the BAN interconnect protocol. Peer entities are 
found on the MBU and on the computing infrastructure (in the ‘fixed’ network). The 
BANip entities communicate through a proxy, which authenticates and authorizes the 
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BANs.  
The surrogate component uses the BANip protocol to obtain BAN data. It contains a 
representation of the deployed BANs (i.e. surrogates). The surrogate component is 
deployed in the fixed network and shields other components in the ‘fixed’ network from 
the BANip and direct interaction with the BAN (for example it hides the intermittent 
availability of the BAN and the use of private IP addresses (Rekhter et al., 1996) for 
GPRS terminals). Thus it solves the problems arising from the invertion of producer and 
consumer roles. The surrogate component can be accessed by any application protocol, 
including Remote Method Invocation (RMI).  
The storage entity uses RMI to interact with the surrogate as if it interacts with the 
remote BAN at the location of the patient, without the responsibility of managing BAN 
discovery, registration and authentication. The surrogate component is therefore the 
intermediary to which BAN data from the location of the patient is pushed and from 
which BAN data is pulled by the application component running in the hospital systems. 
BAN data may also be pushed by the surrogate to the application component. The storage 
entity provides a BAN data storage service to the  
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Applications 
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App’s 
Proxy 
 
  
  
  
BANip 
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RMI RMI 
Storage 
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Figure 6. Refined view of the service platform 
 
application layer. Configuration, discovery and monitoring services are offered as 
separate entities and have a similar structure to the storage entity shown in Figure 6.  
Applications which use the m-health service layer can range from simple viewer 
applications which provide a graphical display of BAN data to complicated applications 
which analyse and interpret the clinical data.  
The Ban Interconnect Protocol (BANip) was implemented using HTTP1.1. The BANip 
is implemented on the MBU as an HTTP client, which collects a number of samples into 
the payload of an HTTP POST request and invokes the post on the surrogate. A standard 
HTTP proxy acts as a security gateway for the surrogate. If the surrogate needs to control 
the MBU, these control commands are carried as the payload of the HTTP reply.  
The surrogate was implemented using the Jini Surrogate architecture (Sun 
Microsystems, 2003b). Jini provides the implementation for auto-discovery and 
registration of the BAN. In terms of the Jini architecture the surrogate is a service 
provider. Other components, such as the BAN data storage component, are service users 
from the perspective of the surrogate.  
Additional security was added by upgrading the BANip protocol from HTTP to 
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HTTPS. This ensures that BAN data is encrypted while it traverses the public wireless 
network and the Internet. 
More details of the BAN service platform implementation may be found in the project 
deliverables, available at the project website and in (Dokovsky et al, 2003). The 
following section gives an overview of the MobiHealth trials and evaluation. 
 
 
3. VALIDATION OF THE MOBIHEALTH APPROACH: TRIALS AND 
EVALUATION  
 
The overall goal of the MobiHealth project is to test the ability of 2.5 and 3G 
infrastructures to support value added healthcare services. The trials span four European 
countries and are targetted at the areas of acute (trauma) care, chronic and high-risk 
patient monitoring and monitoring of patients in home-care settings. The trials cover a 
range of conditions including pregnancy, trauma, cardiology (ventricular arrhythmia), 
rheumatoid arthritis and respiratory insufficiency (chronic obstructive pulmonary 
disease). The trials cover use of patient BANs and health professional BANs (nurse 
BAN, paramedic BAN). The trials were selected to represent a range of bandwidth 
requirements: low (less than 12 Kbps), medium (12 – 24 Kbps) and high (greater than 24 
Kbps) and to include both non-real time (e.g. routine transmission of tri-weekly ECG) 
and real time requirements (e.g. alarms, transmission of vital signs in a critical trauma 
situation). For each application the generic MobiHealth BAN is specialized by addition 
of the appropriate sensor set and corresponding application software. To illustrate the 
validation effort we mention here one trial from each participating trial site. 
. 
3.1  Telemonitoring of patients with ventricular arrhythmia 
 
In Germany the MobiHealth system is tested and evaluated with a cohort of patients 
suffering from ventricular arrhythmias who are undergoing drug therapy for this 
condition. In such patients, ECG measurements have to be taken regularly to monitor 
efficacy of drug therapy. In this trial the patient BAN transmits ECG and blood pressure 
via GPRS to a Medical Service Centre, where vital signs are monitored by physicians and 
nurses. Instead of staying in hospital during monitoring, the patient can be at home and 
can even go freely outside the home. The intention is that through remote monitoring 
developing clinical trends can be identified and corrected before they become serious. 
From a health economic point of view the intervention is expected to save time and 
reduce costs (eg by reduction in number of hospitalizations, and by lowering drug costs). 
For the healthcare/medical evaluation blood pressure and ECG readings during the 
technology intervention are compared to baseline measurements.  
  
3.2  Integrated Homecare in women with high-risk pregnancies 
This Dutch trial evaluates use of the MobiHealth BAN to support Integrated Homecare 
for women with high-risk pregnancies. Women with high-risk pregnancies are often 
admitted to hospital because of possible pregnancy-related complications. Admission is 
necessary for the intensive monitoring of the patient and the unborn child. Homecare with 
continuous monitoring of women with high-risk pregnancies, when feasible, is desirable 
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and can postpone hospitalisation and reduce costs. In this trial, pregnant women are 
monitored from home using the MobiHealth BAN and maternal and foetal signs are 
transmitted to the hospital. The objective of the trial is to evaluate if such monitoring 
services can be supported by 2.5-3G communications such that hospitalisation can be 
postponed and costs reduced. For the healthcare/medical evaluation, main outcome 
parameters are the number of days in hospital, the number of emergency interventions, 
patient satisfaction with hospital or telemonitoring and the reliability of the system to 
monitor the patients and to inform the gynaecologist regarding ECG and EMG data. 
Although the service, if introduced, is intended for high risk patients, for the trials 
themselves high risk patients are not included for obvious reasons. 
.  
3.3 Support of home-based healthcare services 
 
This Spanish trial involves use of GPRS communication for supporting home-based care 
for elderly chronically ill patients, including remote assistance if needed. Trial subjects 
suffer from co-morbidities including Chronic Obstructive Pulmonary Disease. The 
MobiHealth Nurse BAN is used to perform patient measurements during nurse home 
visits and the MobiHealth patient BAN is used for continuous home monitoring and also 
outdoors during patient rehabilitation. It is very important to facilitate patients’ access to 
healthcare professionals without saturating the available resources, and this is one of 
main expected outcomes of the MobiHealth remote monitoring approach explored in this 
trial. Physical parameters measured are oxygen saturation, ECG, spirometry, temperature, 
glucose and blood pressure. The healthcare/medical evaluation focuses on acceptability 
of the technology solution in this health context and compares quality and process of care 
received under the technology intervention with that received under current practice. 
Comparison is in terms of numbers of in-patient hospital stays, ER visits, outpatient 
visits, primary care physician visits, social support visits, nurse home visits, prescriptions, 
phone calls (patient-nurse/ nurse-patient) and transports. 
 
3.4 Home care and remote consultation for recently released patients in a rural 
area 
 
In this Swedish trial the trial subjects are patients with multiple chronic diseases 
including cardiac failure, diabetes and respiratory disability who have been recently 
discharged from hospital and who are living at home in a low population density rural 
area. Measurements (including blood pressure, heart rate, oxygen saturation and blood 
glucose, as appropriate) are transmitted to a remote physician or a registered district nurse 
(RDN). The intention is that the remote health professional receives clinical data which 
offers a better basis for a good and safe decision on whether the patient needs transfer by 
ambulance to hospital. The expected benefit is that this intervention will reduce the 
number of cases where the patient is moved to hospital unnecessarily. The 
healthcare/medical evaluation will focus on qualitative instruments measuring user 
experiences of the intervention by the involved roles: staff, patients and their next-of-kin. 
The trials are evaluated in terms of accuracy and validity of measurements, usability of 
the GPRS and UMTS networks, business and market potential and also in terms of social 
and ethical effects. 
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 All trials are evaluated according to four perspectives: Technology, 
Healthcare/Medical, Market and Social. It cannot be expected that any definitive clinical 
outcomes can be established with the patient numbers and timescales involved. In fact 
under the context of the Call the primary evaluation focus must be on the technology, 
specifically on the potential for value added services over 2.5 and 3G communications. 
The results of the evaluation will be available in 2004. 
 
 
4. FUTURE CHALLENGES AND RESEARCH ISSUES RAISED  
 
In the wider context, assessment and evaluation of the value of innovative m-health 
solutions and the incorporation of worthwhile m-health technologies into existing 
healthcare systems in terms of structure, organization and working practices presents 
many challenges. Legal issues and hospital responsibilities such as ownership of the data 
and legal liability are complicated by the international dimension enabled by the 
opportunity of seamless access to services for free roaming patients. With the new 
possibilities come new challenges. These challenges give direction for future research 
across a range of disciplines.  
For our own discipline of computing science, we see (horizontal) research issues 
arising from MobiHealth in connection with adaptive applications and communications, 
and vertical research issues such as security, quality of service and scalability. Some of 
these research issues are listed below: 
Mobile service platforms: how to make scalable, platform independent, generic BAN 
service platforms which can be rapidly configured for different applications and device 
sets. 
Ad hoc networking: investigation of the role of BANs and PANs and  the relationship 
and communication within and between them. 
How to provide seamless vertical handover between wireless technologies, across the 
wired/wireless divide and across operator domains. 
Adaptive applications and IUIs: how to design intelligent adaptive (dynamically 
reconfigurable) BAN applications, and how to design Intelligent User Interfaces for the 
resulting BAN services. 
How to ensure security, privacy, safety, correctness and quality of service of systems 
and information based on wireless communications infrastructures, ambient intelligent 
environments and ad hoc networking.  
Scalability: how to support large populations of deployed BANs as part of offered 
clinical services. This implies high performance distributed computing, broadband 
wireless communication and automation of clinical analysis and interpretation. For some 
applications automated analysis will involve complex real time pattern recognition and 
application of (temporal) abstraction to effect clinical interpretation. This in turn implies 
that BAN applications interface to large scale and comprehensive clinical knowledge 
bases and inferencing systems. Emerging technologies such as GRID computing may 
play a role at the infrastructure level by providing the fast processing, high volume 
storage and reliable communication resources required. 
We expect that in the longer term the current style of implementation of (health) 
BANs will disappear, replaced by nanoscale devices and contactless sensing from the 
ambient intelligent environment. We call this vision the Ambient Intelligent BAN or AmI 
BAN). AmI BAN devices might be implanted rather than worn externally on the body or 
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in clothing. These devices could include for example actuators to control drug delivery 
systems, nanomanipulators or neural stimulators interfacing directly to motor neurons.  
The vision of the future depends on scientific research and technological advances not 
only in computing science but also from other technical disciplines including electrical 
engineering, physics and nanoscience. Wearable computing, nanotechnologies, 
contactless sensing, implantable devices and low-power or self-powered devices are 
some of the enabling technologies prerequisite to the realization of the vision. Together 
these multidisciplinary developments can open the way for seamless collaboration 
between BANs, PANs and the ambient intelligent environment.  
Even for the medium term future many problems remain. Apart from the challenges for 
computing science and other technical disciplines, experience in  many application 
domains indicates that the success factors for take up of technical innovation come from 
the larger extra-technical context. These factors include organisational and professional 
issues from the application domain concerning the impact on ways of working, and user 
acceptance.  
In the healthcare domain, first and foremost the technology must gain public 
acceptance and be perceived as bringing benefits to patients. Of primary concern are 
potential health benefits, but impact on quality of life for patients and for the patients’ 
families are also part of the very important patient ‘utility function’. Clinical effects such 
as efficacy can be addressed by means of clinical trials. Determining the effects of new 
health technology on process and outcome of care and subjective factors such as user 
satisfaction and quality of life are the domain of Health Services Research (HSR) studies. 
Research in the areas of e-health and e-learning indicates that innovation is embraced by 
users only when they perceive immediate benefits.  
Regarding the organisational aspects of healthcare, exploitation of a technical 
innovation may imply extensive and radical business process re-engineering of the 
(national) healthcare system. Such implications have caused many (technically sound) 
health technology innovations to fail in the past. Unless business process re-engineering 
is driven by and accepted by the stakeholders, including the patients, the profession, the 
payers (eg. health insurance companies) and the policy makers, the most promising health 
technology innovation is likely to fail. Evolutionary change is more likely to succeed than 
revolutionary change and we believe that provision of m-health services as a 
supplementary part of the service package from healthcare providers is one possible path 
in such incremental change in service delivery. 
The economic impact of introduction of new technology can also make the difference 
between success and failure in take-up of the innovation. This is the area of study for 
health economists. A comprehensive cost benefit analysis should take into account all the 
direct and indirect financial costs (including cost savings) and set them against the non-
financial factors, that is the benefits (such as improved health outcomes or increased user 
satisfaction) and the disbenefits, for all the stakeholders. 
A further set of challenges involves the ethical, legal and regulatory issues associated 
with the use of BANs and the offering of mobile healthcare services. 
 
 
5. CONCLUSIONS   
 
At time of writing the MobiHealth project has been running for 17 months (since May 
2002). In the rather short duration of the project a great many problems and challenges 
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have been encountered and much progress has been made. The starting point was a vision 
of ubiquitous mobile health services based on Body Area Networks. During the project 
we have designed and prototyped a health BAN and a BAN service platform and 
developed services for different patient groups according to the requirements specified by 
the clinical partners. Patient trials have begun during which evaluation data will be 
collected and analysed. 
MobiHealth has resulted in an early prototype of the BAN, engineered mainly by 
integration of existing technologies without focusing on miniaturization or optimisation 
of power consumption. The main focus has been on the architecture, design and 
implementation of an m-health service platform. The result is a first version of a service 
platform whose architecture is comprised of a set of clearly defined components.  
Perhaps ironically, the greater the potential of such services for the population at large, 
the bigger the problem of scalability of solutions becomes. We believe our solution to be 
scalable. Each of the service components can be replicated on multiple servers and, with 
implementation of a load balancing strategy, can serve a large user group. We expect the 
platform to be scalable to a large-scale remote healthcare monitoring situation, defined as 
100,000 plus BANs. During the course of the project we believe we have reached a better 
understanding of the services such a platform should offer.  
Prospects of substituting the IPAQ MBU platform with a Sony Ericsson P800 seem 
promising. As well as allowing substitution of the MBU platform, the generic service 
platform enables integration of BAN devices from different manufacturers. During the 
current project sensors from different sources, including front-end supported and self-
supporting sensors, have been integrated into the BAN. Thus the objective of platform 
independence is being fulfilled. 
It should not be thought however that all problems have been overcome even with use 
of current technologies. Ambulatory monitoring is more successful for some biosignals 
than others, for example some measurements are severely disrupted by movement 
artifacts. Some monitoring equipment is still too cumbersome for ambulatory use, 
because of the nature of the equipment or because of power requirements. In the area of 
wireless (tele)communication technologies (even with 2.5 and 3G) we still suffer from 
limited bandwidth for some applications, such as those which require serving many 
simultaneous users with conversational applications requiring high quality two-way audio 
and video, or generation of 3D animation in real time.  
The use of BANs and wireless communications in personal healthcare systems still 
raises important challenges relating to security, integrity and privacy of data during 
transmission. This applies to both local transmission (eg. intra-BAN, BAN-PAN) and 
long range (eg. extra-BAN) communications. End-to-end security and Quality of Service 
guarantees need to be implemented. Safety of hardware (eg. electrical safety, emissions, 
interference) and reliability and correctness of applications must also be a priority in 
deployment of mobile services. Comfort and convenience of sensors or BANs worn long 
term for continuous monitoring is important for usability and user acceptance. Timeliness 
of information availability in the face of unreliable performance of underlying network 
services is another issue. Provision of seamless services across regional and national 
boundaries multiplies these difficulties. Powering always on devices and continuous 
transmission will continue to raise technical challenges. Business models for healthcare 
and accounting and billing models for network services need to evolve if technical 
innovations are to be exploited fully. Standardisation at all levels is essential for open 
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solutions to prevail. At the same time specialization, customisation and personalisation 
are widely considered to be success criteria for innovative services.  
Emerging technologies such as nanotechnology, smart sensors, ambient intelligent 
environments, grid computing, advanced power management and new implantation 
techniques open up many future possibilities for innovative mobile health services, 
however we expect that, along with these advances, issues such as quality of service, 
safety, security and privacy will pose ever more interesting challenges in the future. 
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